Homeopathic products are marketed without FDA review and may not meet modern standards for safety, effectiveness, quality and labeling. Learn more.
Similar Posts
Asahi Kasei Finechem Co., Ltd. – 11/14/2025
Asahi Kasei Finechem Co., Ltd. – 11/14/2025. Country: Japan. Record Type: 483Complex Innovative Trial Design Meeting Program
As displayed in the Federal Register notice on August 1, 2018, FDA is conducting a Complex Innovative Designs (CID) Meeting Program to support the goal of facilitating and advancing the use of complex adaptive, Bayesian, and other novel clinical trial designs, as highlighted in the sixth iteration oWinder Laboratories, LLC – 718601 – 01/07/2026
CGMP/Finished Pharmaceuticals/AdulteratedFDA Warns 30 Telehealth Companies Against Illegal Marketing of Compounded GLP-1s
The U.S. Food and Drug Administration today announced the issuance of 30 warning letters to telehealth companies for making false and misleading claims regarding compounded GLP-1 products offered on their websites.Zydus Lifesciences Limited – 08/13/2025
Zydus Lifesciences Limited – 08/13/2025. Country: India. Record Type: 483Tri-Union Seafoods Identifies Additional Quantities of Recalled Genova® Tuna at Limited Retailers Due to Inadvertent Distribution of Previously Recalled Product
El Segundo, CA, January 16, 2026 – Tri-Union Seafoods is cautioning consumers that a third-party distributor inadvertently released quarantined product that was associated to a February 2025 recall. The initial voluntary recall was conducted following notification from our supplier that the “easy op